H. E. M. Kay
- Hematology top 5%
- Genetics top 10%
- Hemoglobinopathies and Related Disorders 2
- Virus-based gene therapy research 1
-
- Cancer, Hypoxia, and Metabolism 1
-
- Immunotherapy and Immune Responses 2
-
- Radiopharmaceutical Chemistry and Applications 1
-
- Myasthenia Gravis and Thymoma 1
-
- Eosinophilic Esophagitis 1
-
- Drug-Induced Adverse Reactions 1
- Co-authors
- J. M. A. WhitehouseKevin R. McCarthyJ. S. PorterfieldRonald Bodley ScottBeryl JamesonCharles S. AugustFred S. RosenRobert M. Filler
- Cited by
- HematologyGeneticsAging
- Journals
- The Lancet (2 papers)JNCI Journal of the National Cancer Institute (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
H. E. M. Kay
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 132
- Hematology 171
- Genetics 101
- Aging 12
- Cancer Research 99
- Molecular Biology 449
Countries citing papers authored by H. E. M. Kay
This map shows the geographic impact of H. E. M. Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. M. Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. M. Kay more than expected).
Fields of papers citing papers by H. E. M. Kay
This network shows the impact of papers produced by H. E. M. Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. M. Kay. The network helps show where H. E. M. Kay may publish in the future.
Co-authorship network
The 9 scholars most cited alongside H. E. M. Kay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Enzyme Defects and Immune Dysfunction: Ciba Foundation Symposium 68 (New Series) | 1980 | 1 |
| 2 | 1979 | 3 | |
| 3 | 1974 | 1 | |
| 4 | 1973 | 200 | |
| 5 | 1971 | 87 | |
| 6 | 1971 | 216 | |
| 7 | 1970 | 1 | |
| 8 | 1970 | 54 | |
| 9 | 1970 | 5 | |
| 10 | 1970 | 114 | |
| 11 | 1969 | 8 | |
| 12 | 1968 | 4 | |
| 13 | 1967 | 5 | |
| 14 | 1966 | 14 | |
| 15 | 1965 | 1 | |
| 16 | 1965 | 160 | |
| 17 | 1964 | 44 | |
| 18 | 1964 | 14 | |
| 19 | 1961 | 21 | |
| 20 | 1959 | 17 |
About H. E. M. Kay
H. E. M. Kay is a scholar working on Genetics, Biochemistry and Immunology, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Virus-based gene therapy research (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Myasthenia Gravis and Thymoma (1 paper), Eosinophilic Esophagitis (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Drug-Induced Adverse Reactions (1 paper). The work is most often cited by research in Hematology (171 citations), Genetics (101 citations) and Aging (12 citations). H. E. M. Kay has collaborated with scholars based in United Kingdom. Frequent co-authors include J. M. A. Whitehouse, Kevin R. McCarthy, J. S. Porterfield, Ronald Bodley Scott, Beryl Jameson, Charles S. August, Fred S. Rosen, Robert M. Filler and Charles A. Janeway. Their work appears in journals such as The Lancet, JNCI Journal of the National Cancer Institute and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.